To determine the accuracy of the UA-85X 852, 853, 854, and 855) device developed by the A&D company. Device evaluations were performed using the protocol of the European Society of Hypertension (ESH). Monitor performance was assessed in relation to patients' age, arm circumference, and systolic and diastolic blood pressures (BPs). The device was assessed in two different samples according to ESH requirements, which are based on four zones of accuracy differing from the mercury standard by 5, 10, 15 mmHg, or more. The UA-85X passed all three phases of the protocol for systolic BP and diastolic BP. Mean BP difference between device and observers was -0.3 ± 4.4 mmHg for systolic BP and -2.7 ± 4.8 mmHg for diastolic BP. These passed the Association for the Advancement of Medical Instrumentation standard requirements. In multivariable analyses, systolic BP discrepancies between device and observers were related to age (P = 0.03) and diastolic BP discrepancies were related to diastolic BP level (P < 0.001). These data show that the UA-85X satisfies the recommended ESH and Advancement of Medical Instrumentation accuracy levels for both systolic BP and diastolic BP.
Introduction
Concerns about mercury toxicity have seriously threatened the future of mercury sphygmomanometry for blood pressure (BP) measurement [1, 2] . This has increased the interest of doctors and manufacturers in mercury-independent devices. Many automated devices are available today, which might replace the traditional technique. Only some of them, however, proved to be reliable when tested against traditional sphygmomanometry according to the suggestions of international protocols [3, 4] . A possible drawback with automatic devices is the time spent by the patient during each BP measurement. A fast cuff deflation would significantly shorten the time needed for each measurement, allowing for more BP readings during a particular time period. The A&D company recently developed an oscillometric device for home BP measurement, the UA-85X (A&D Company Limited, No. 3-23-14, Higashi-Ikebukuro, Toshima-ku, Tokyo, Japan), which performs a rapid cuff deflation (6 mmHg/s) after systolic BP has been obtained. This study reports on the accuracy of this device evaluated according to the protocol of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension (ESH) [4] .
Methods Patients
Thirty-three patients (13 men) with the range of BP required by the ESH rules were included in the protocol. Their mean ± SD systolic BP at entry was 142.5 ± 24.5 mmHg (range: 96-180), and their diastolic BP was 86.8 ± 14.6 mmHg (range: 60-112). Arm circumference was 29.8 ± 2.9 cm (range: 26-38). Mean age was 54.5 ± 17.5 years and the range was slightly wider (21-86 years) than that suggested by the ESH protocol. No patient had atrial fibrillation or other relevant cardiac arrhythmias. All patients agreed to participate in the protocol and gave informed consent.
Device
The UA-85X is an automatic oscillometric BP monitor for the upper arm. Its measuring range spreads 30-280 mmHg for systolic BP, 20-200 mmHg for diastolic BP, and 40-180 bpm for heart rate. Inflations and deflations are controlled by an automatic electronic system. After systolic BP has been obtained, the deflation speed is approximately 6 mmHg/s. A standard cuff is suitable for circumferences of arm ranging 22-32 cm. Cuffs for larger arms are available (Appendix). The UA-85X includes five models (UA-851, 852, 853, 854, and 855). These models are identical except for shape and weight, memory size, and accessories (Appendix). Thus, the validation should be extended to all models, even though the UA-853 was the only model tested in this study.
Device validation
The details of the ESH protocol were published elsewhere [4] . Shortly, sequential same-arm measurements were performed. Two observers took BP measurement with a mercury sphygmomanometer at the left arm using an adult cuff, whose bladders had to cover at least 80% of the circumferences of the arm. Only a discrepancy between the two observers smaller than 4 mmHg was accepted, otherwise the measurement was repeated. Before starting the test, the two observers took a BP measurement and the mean of these two values was used to determine the BP class in which the patient was allocated. Large size cuffs were used in the patients with arm circumference greater than 32 cm (Appendix).
The discrepancy between the reading provided by the sphygmomanometer and the mean of observers measurements was allocated in four zones of accuracy [4] . The first three zones (zone 0, 1, and 2) include discrepancies r 5, r 10, and r 15 mmHg, respectively. The fourth zone (zone 3) includes all measurements.
Data are mean ± SD. Pearson's test with Bonferroni's correction was used for correlations. Predictors of the discrepancy between observer and device measurements were included in linear multivariable regression analyses. Only P < 0.05 was considered as statistically significant.
Results
In the first phase (Table 1) , the analysis was performed in a group of 15 patients (seven men): three measurements were taken for each patient for a total of 45 BP readings. For systolic BP, 35, 45, and 45 device measurements fell in zone 0, 1, and 2, respectively. For diastolic BP 36, 42, and 45 measurements fell in zones 0, 1, and 2, respectively. As the ESH protocol requires at least 25, 35, and 40 measurements in zone 0, 1, and 2, respectively, this phase was passed. In the second phase, the analysis was performed in all 33 patients. The device gave 75, 98, and 99 successful measurements for systolic BP, and 69, 93, and 99 successful measurements for diastolic BP, falling in zones 0, 1, and 2, respectively. According to ESH rules, this phase requires at least 60, 75, and 90 measurements, in zone 0, 1, and 2, respectively, and was, thus, successfully completed. In addition, the second part of phase 2 (phase 2.2) of ESH protocol was passed by the device ( Table 1 ). The observer-device disagreement was -0.3 ± 4.4 mmHg for systolic BP and -2.7 ± 4.8 mmHg for diastolic BP (Fig. 1) . In univariate analyses, no relationship was found between the device-observer systolic BP differences and age, entry systolic BP, and arm circumference. In multivariable regression including the above clinical variables and sex, only age showed a weak association with the device-observer BP differences (P = 0.03). For diastolic BP differences, a significant association was found with diastolic BP level in both univariate (P < 0.001) and multivariable analyses (P < 0.001).
Discussion
Goal of Health Systems worldwide is to maintain a mercury-free environment in the near future [1, 2] . Automatic oscillometric devices may be a reliable Plot of the systolic (upper plot) and diastolic (lower plot) observerdevice blood pressure (BP) differences. The x-axis represents the mean of the device and observer measurements in mmHg. The y-axis represents the difference between the device and observer measurements in mmHg. A positive value indicates that the observer's measurement is greater than the device measurement.
alternative to mercury sphygmomanometers for both doctors and patients, provided they are validated according to international protocols [3, 4] . The results of this study demonstrate that the UA-85X provides accurate and reliable BP measurements across a wide spectrum of patients with different clinical characteristics. The UA-85X model is provided with a fast cuff deflation system, which reduces the time spent for the measurement of diastolic BP. In this study, we observed a tendency for the A&D device to slightly underestimate the diastolic BP obtained with the mercury sphygmomanometer, especially in patients with high diastolic BP level at entry. Fast cuff deflation might lead to greater underestimation of diastolic BP in patients with low heart rate but this hypothesis was not tested in our study. The mean difference was, however, less than 3 mmHg, and the standard deviations of the device-observer discrepancies were well within the Advancement of Medical Instrumentation (AAMI) requirement of a standard deviation of less than 8 mmHg [5] . We thus conclude that the UA-85X is an accurate device that may replace the traditional mercury sphygmomanometer in clinical practice and that may be recommended to patients for home BP measurement.
